X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

mRNA Vaccines and Therapeutics Companies

This report lists the top mRNA Vaccines and Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the mRNA Vaccines and Therapeutics industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Finished Dosage Form Research Vaccines Research mRNA Vaccines Therapeutics Market Companies

mRNA Vaccines and Therapeutics Top Companies

  1. Pfizer Inc.

  2. Moderna, Inc.

  3. BioNTech SE

  4. GlaxoSmithKline

  5. Daiichi Sankyo

*Disclaimer: Top companies sorted in no particular order

mRNA Vaccines and Therapeutics Market Major Players

mRNA Vaccines and Therapeutics Market Concentration

mRNA Vaccines and Therapeutics Market Concentration

mRNA Vaccines and Therapeutics Company List

                                • Pfizer Inc.

                                • Moderna Inc.

                                • BioNTech SE

                                • Daiichi Sankyo

                                • GlaxoSmithKline

                                • Arcturus Therapeutics Inc.

                                • CureVac

                                • AIM Vaccine

                                • Ethris GmbH

                                • Sino Biopharmaceutical Limited (pHion Therapeutics Ltd)

                                • AstraZeneca


                            Specific to mRNA Vaccines and Therapeutics Market
                            Need More Details On Market Players And Competitors?
                            Download Sample

                            mRNA Vaccine and Therapeutics Market Report Snapshots

                            mRNA Vaccine and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)